Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal misoprostol for reducing blood loss during and after cesarean delivery
ACTRN12611000638932Phase 4Completed
- Sponsor
- Mervat Sheikh Elarab Elsedeek Omran
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of misoprostol in postpartum hemorrhage (PPH) (2 arms), sponsored by Mervat Sheikh Elarab Elsedeek Omran. Primary endpoints: Amount of blood loss during cesarean delivery and Amount of postpartum blood loss. Started Jan 2008; status: completed.
02
Drugs
misoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on ACTRN12611000638932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000638932.